Abstract

BackgroundThe instant-treatment effect of acupuncture for patients with migraines has been corroborated in numerous studies. However, most diseases are chronic and tend to recur, so the long-term effect of acupuncture can verify the existence of sustained efficacy or the placebo effect. Evaluating the efficacy of acupuncture in the prophylaxis of migraine without aura (MWoA) in China is also important because such studies are lacking.MethodsThis trial is a multicenter, prospective, pragmatic randomized controlled clinical trial. We will randomly allocate 249 participants to three groups of 83. Patients in the individualized acupoint group will be treated with individualized acupuncture point prescriptions. The non-acupoint control group will undergo insertion of acupuncture needles at four bilateral non-points in locations not corresponding to acupuncture points. The waiting-list control group will not undergo treatment but instead will receive 20 acupuncture treatments for free after a waiting period of 24 weeks. Participants in the individualized acupoint group and non-acupoint control group will receive 20 sessions over four weeks and then all participants will receive 20 weeks of follow-up.DiscussionThe results of our trial will help to supply evidence for the long-term acupuncture effect for MWoA in a long follow-up period, and special attention will be paid to comparison with the placebo effect.Trial registrationThe trial was registered at ClinicalTrials.gov (NCT01687660) on 18 September 2012.

Highlights

  • The instant-treatment effect of acupuncture for patients with migraines has been corroborated in numerous studies

  • Pragmatic and explanatory randomized controlled trials play a significant part in the evaluation of healthcare interventions in China and overseas [29]

  • Pragmatic trials are used to discover how effective a treatment is in routine everyday practice, with the aim of providing evidence that will help policymakers, practitioners or patients make choices between two interventions [30]

Read more

Summary

Methods

The design of this study is in accordance with the guidelines of the International Headache Society’s (IHS) Committee on Clinical Trials in Migraine [22]. Design This randomized, controlled, multicenter pragmatic trial comprises three parallel groups. Random numbers and group assignment will be confirmed immediately through Email or short message service (SMS) to the independent assessor. This procedure guarantees that randomization concealment is adequate, and not influenced by the acupuncturists or participants. Participants will be: informed (verbally and through a print-out) of the possible risks associated with the study; instructed to complete the headache diary; told that they can withdraw from the trial at any time without specifying reasons; and told that they can voluntarily provide written informed consent before enrollment

Discussion
Background
Participants excluded
24. Headache Classification Subcommittee of the International Headache Society
31. Witt C
38. Oken B
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call